Preformulation Study Service
Preformulation studies characterize physical and chemical properties of a drug molecule alone or combined with excipients at early stage of drug product development to ensure formulation and process development can be carried out leading to a safe, effective, stable, and manufacturable dosage form. Sometimes, the property characterization of functional excipients (e.g. rate-controlling component) is also important to successfully develop a novel dosage form with a desirable release profile. Preformulation studies can be conducted in vitro throughout the drug product development from pre-clinical studies, clinical studies, to final scaling up for commercial launch. Established data from preformulation studies are required by the regulatory agencies to compose the CMC sections.
Services Provided in Preformulation Studies
Preformulation Capabilities
Property Characterizations for NCE/API and Drug Product
PreFormulation Instruments
Selection of Dosage Forms for Preclinical Studies
Pre-clinical study in drug development is a stage of research before clinical trials which tests a new chemical entity (NCE) in animals to collect information about drug safety and potential administration route, etc. The aim of a pre-clinical study is to determine the safe dose for first-in–human and assess a product’s safety profile. We can help to select the best dosage forms for the NCE based on our strengths in preformulation studies and formulation and process development, and produce the supplies of drug product from pre-clinical to Phase I clinical studies.
Capabilities for Early Formulation Services
Supporting Preclinical and FIH Clinical Studies
Basic Dosage Forms for Preclinical Studies
Phase 1 Clinical Supply
With the help of our strength in formulation design and characterization of new drug candidates, our expertise covers the aspects of early drug product development including the preformulation studies and formulation, and process development of novel dosage forms. Our goal is in line with our client’s goal to make rapid deliverable drug product supplies in support of preclinical to Phase I clinical studies.Service to Support Phase 1 Clinical Studies
Phase 1 Supply Equipment
